Tetramethylpyrazine ameliorates renal inflammation via autophagy induction in acute kidney injury

Rui Xin; Rui Xin; Long Jin; Long Jin; Luying Liu; Luying Liu; Lin Wang; Lin Wang; Yun Hou; Yun Hou; Xianghui Meng; Xianghui Meng; Yanxiao Xiang; Yanxiao Xiang; Xuhong Sun; Xuhong Sun; Weidong Jiang; Weidong Jiang; Xiaojie Wu; Xiaojie Wu; Lixia Zhang; Lixia Zhang; Zhenzhen Du; Zhenzhen Du; Xiying Luan; Xiying Luan; Pengchao Du; Pengchao Du

doi:10.18632/oncotarget.24036

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/06/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Tetramethylpyrazine ameliorates renal inflammation via autophagy induction in acute kidney injury

Rui Xin _, Rui Xin, Long Jin, Long Jin, Luying Liu, Luying Liu, Lin Wang, Lin Wang, Yun Hou, Yun Hou, Xianghui Meng, Xianghui Meng, Yanxiao Xiang, Yanxiao Xiang, Xuhong Sun, Xuhong Sun, Weidong Jiang, Weidong Jiang, Xiaojie Wu, Xiaojie Wu, Lixia Zhang, Lixia Zhang, Zhenzhen Du, Zhenzhen Du, Xiying Luan, Xiying Luan, Pengchao Du and Pengchao Du _

Rui Xin1,*, Long Jin2,*, Luying Liu1,*, Lin Wang3, Yun Hou1, Xianghui Meng4, Yanxiao Xiang5, Xuhong Sun1, Weidong Jiang3, Xiaojie Wu1, Lixia Zhang6, Zhenzhen Du6, Xiying Luan1 and Pengchao Du1,*

1 College of Basic Medical, Binzhou Medical University, Yantai, Shandong, China

2 The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China

3 The Second Hospital of Shandong University, Jinan, Shandong, China

4 Central hospital of ZiBo (GaoQing branch courts), Zibo, Shandong, China

5 Qilu Hospital, Shandong University, Jinan, Shandong, China

6 Binzhou Medical University, Yantai, Shandong, China

* These authors have contributed equally to this work

Correspondence to:

Pengchao Du, email: [email protected]

Keywords: NOD2; autophagy; TMP; acute kidney injury

Received: July 27, 2017 Accepted: December 01, 2017 Epub: January 06, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24036

Publication Alerts

Withdrawal Notice

Research Papers:

Tetramethylpyrazine ameliorates renal inflammation via autophagy induction in acute kidney injury